A

ADOCIA

106 employees

Adocia is a biotechnology company specializing in tissue regeneration and developing medicines with already-approved therapeutic proteins.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
BioChaperone®
Next-generation injectables for diabetes treatment
Glucagon
Amylin
Metabolic diseases
Ultra-rapid Insulin
Therapeutic proteins
Innovative protein formulations
Multi-agents injectable combination
Therapeutics
Alternative Medicine
Diabetes

Date founded

2005

Funding rounds raised

Total raised

$20M

from 5 investors over 5 rounds

A

ADOCIA raised $20M on January 27, 2010

Investors: La Caisse des Dépôts (French financial institute) and Idinvest Partners

A

ADOCIA raised $17M on January 21, 2008

Investors: Société Générale Asset Management, Smalt Capital and Idinvest Partners

FAQ